Elan Says Antegren Trial for Crohn's Successful
Irish pharmaceutical firm Elan Corp Plc raised market hopes for its much-vaunted experimental drug Antegren on Thursday after it announced successful results from a key clinical trial on Crohn's disease.
Data from Phase III studies of Antegren's effect on MS are expected by late 2004 or early 2005.
I am 81 years of age and have suffered from Crohns for over 30 years and I look forward with great interest in the development of Antegren.
Crohns stopped me playing golf, can Antegren kick-start me off again?
Posted by: Alan Johnson at Sep 9, 2004 7:02:40 AM